A medical conference in Dubai discusses the role of artificial intelligence in treating kidney disease and diabetes
Dubai, April 13 / WAM / The activities of the 25th session of the Faculty of Kidney Doluguration, metabolic syndrome and organ transplant, organized by the University Hospital, in cooperation with Ras Al Khaimah University for Medicine and Health Sciences, Sharjah University and the Kidney Division of the Emirates Medical Association, Dubai Health Authority and the “Hayat” Association for organ transplantation.
Participated in the conference, which lasted for more than 715 doctors and technicians from medical staff specialized in kidney disease and various internal medical specialties from inside and outside the country, and discussed the role of artificial intelligence in treating kidney disease, diabetes and immunological infections in the kidneys.
Dr. Abdul Basit Al -Essawy, a visiting professor in Al -Batiniya and a researcher at the American Harvard University and the University of Fakih Hospital in Dubai, President of the Conference, pointed out that 48 lectures, professors and consultants will participate in the new session of this specialized medical conference, from Harvard universities and “John Hopkin” in the United States, and the University of “Milan in Italy, and from other universities in Spain, Australia, Egypt and Saudi Arabia Kuwait and Lebanon.
He explained that the conference focused on the importance of raising awareness of organ transplantation, especially from newly and new deaths in the treatment of kidney disease, which is caused by diabetes and modern medicines, which treat diabetes, protect the heart, kidneys and liver and contribute to weight reduction, pointing out that during the conference sessions, the role of genetic analysis was highlighted, and the new in using urine analysis to early detecting those exposed to kidney disease in order to take preventive measures.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
